Accessibility Menu
Benchmark Plc logo

Benchmark Plc(LSE) BMK

This security has been delisted. This page is retained for historical reference.

Benchmark Plc last closing stock price
MetricPriceDate
Last closeGBX 22.052025-08-15
Benchmark Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.78%GBX 20.652025-08-08
1 month-10.37%GBX 24.602025-07-16
3 month-2.43%GBX 22.602025-05-16
Year to date-33.98%GBX 33.402024-12-31
1 year-44.88%GBX 40.002024-08-15
3 year-49.31%GBX 43.502022-08-16
5 year-46.22%GBX 41.002020-08-14
Since inception-70.15%GBX 0.742013-12-18

BMK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

BMK Financials

Key Financial Metrics (TTM)

Gross Margin

48.63%

Operating Margin

-39.28%

Net Income Margin

-43.67%

Return on Equity

-15.96%

Return on Capital

-12.23%

Return on Assets

-10.25%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

£24.26M

Operating Income

-£40.15M

EBITDA

-£2.81M

Operating Cash Flow

£6.81M

Capital Expenditure

-£4.27M

Free Cash Flow

£2.54M

Cash & ST Invst.

£207.51M

Total Debt

£81.61M

Benchmark Plc Performance Analysis

Benchmark Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-09-30GBP 125,062,000N/A
20222022-09-30GBP 157,707,00026.1%
20232023-09-30GBP 103,963,000-34.1%
20242024-09-30GBP 90,365,000-13.1%
Benchmark Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-06-30-22.8%
Q42024-09-30-167.0%
Q12024-12-31186.2%
Q22025-03-3129.2%
Benchmark Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-09-30GBP -0.02N/A
20222022-09-30GBP -0.05138.3%
20232023-09-30GBP -0.03-31.3%
20242024-09-30GBP -0.0569.0%
Benchmark Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-06-30-644.4%
Q42024-09-30-108.2%
Q12024-12-3164.9%
Q22025-03-311324.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

£22.91M

-42.4%

Gross Profit

£11.99M

-10.2%

Gross Margin

52.34%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

800

N/A

Net Income

£86.44M

+6643.6%

EBITDA

£893.00K

-90.6%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

£207.51M

+899.6%

Total Debt

£81.61M

-12.7%

Accounts Receivable

£63.21M

+15.8%

Inventory

£24.38M

-49.1%

Long Term Debt

£2.27M

-97.0%

Short Term Debt

£79.34M

+358.8%

Return on Assets

-10.25%

N/A

Return on Invested Capital

-14.88%

N/A

Free Cash Flow

£9.51M

+1686.7%

Operating Cash Flow

£10.97M

+657.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MXCT.LMaxCyte, Inc.
£1.48-7.69%
ETX.LE-therapeutics Plc
£0.09-6.74%
REDX.LRedx Pharma Plc
£0.15+31.58%
CNSL.LCambridge Nutritional Sciences plc
£0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
TAT&T
$24.13+0.05%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.